MFS
ORIC icon

Mirabella Financial Services’s Oric Pharmaceuticals ORIC Stock Holding History

Mirabella Financial Services’s Portfolio ORIC Stock Details ORIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-13,500
Closed -$72K – 643
2022
Q1 		$72K Buy
+13,500
New +$122K 0.01% 463
2020
Q4 		– Sell
-9,318
Closed -$233K – 437
2020
Q3 		$233K Buy
+9,318
New +$222K 0.03% 256

Other funds holding ORIC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CG
Column Group San Francisco, California $88.1M AUM 148.03% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $74.1B AUM 71.18% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return

Mirabella Financial Services's ORIC Position: Q2 2022 in Review

Mirabella Financial Services sold out of Oric Pharmaceuticals (ORIC) in Q2 2022, closing a stake of 13,500 shares — an estimated $72K sold.

Mirabella Financial Services first reported a position in ORIC in Q3 2020 and held it in 2 quarters. The position peaked at $233K in Q3 2020. 83 funds tracked by Wall St. Rank hold ORIC as of Q2 2022.

  • Mirabella Financial Services reported no remaining Oric Pharmaceuticals position as of Q2 2022 after selling out during the quarter.
  • Mirabella Financial Services sold 13,500 Oric Pharmaceuticals shares in Q2 2022, an estimated $72K.
  • Mirabella Financial Services first reported a position in Oric Pharmaceuticals in Q3 2020 and held it in 2 quarters.
  • Mirabella Financial Services's Oric Pharmaceuticals position peaked at $233K in Q3 2020.
  • 83 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q2 2022.

Based on Mirabella Financial Services's 13F filing for Q2 2022, filed 12 Aug 2022.